- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05379738
Impact of Adapted Physical Activity on Patient's Recovery Following Allogeneic Stem Cell Transplantation for Hematological Malignancy (APALLO)
January 29, 2024 updated by: Centre Hospitalier Universitaire de Nice
APALLO : Post Allogeneic Stem Cell Transplantation Adapted Physical Activity for Patient With Hematological Malignancies
It is a study about adaptated physical activity for patients receiving a stem cell transplantation.
They will benefit of 6 adaptated individuals lessons at home between 1 month and 3 months after stem cell transplantation.
The study's goal is to observe if adaptated activity has an positive impact on weight loss and on life quality.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
75
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: SOLDATI Alizée
- Phone Number: 04 92 03 96 27
- Email: soldati.a@chu-nice.fr
Study Contact Backup
- Name: LOSCHI Mickael, MD
- Phone Number: 04 92 03 90 25
Study Locations
-
-
-
Nice, France
- Recruiting
- CHU NICE, hopital ARCHET 1, hématologie
-
Contact:
- SOLDATI Alizée
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion criteria :
- Patient aged 18 or more
- Patient with social security
- Patient who accept the study and sign the consent form
- Patient programmed for an allogenic stem cell transplantation
Non inclusion criteria :
- Patients with a guardianship
- Patients with a significant additional physic or mental disease
Exclusion criteria
- Patients who did not receive an allogeniac stem cell transplantation
- Patients still hospitalized between day 30 and day 100 after stem cell transplantation
- Patients who finally refuses the study
- Patients who develop a physical or mental incapacity to practice physical activity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: adapted physical activity
6 sessions of physical activity
|
physical assessement before and after stem cell transplant:
psychometric assessment before and after stem cell transplant:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
weight loss
Time Frame: before stem cell transplantation, 1 month , 3 months, 1 year after stem cell transplantation
|
Body weight n in kilograms
|
before stem cell transplantation, 1 month , 3 months, 1 year after stem cell transplantation
|
|
weight loss
Time Frame: before stem cell transplantation, 1 month , 3 months, 1 year after stem cell transplantation
|
Calculation of the percent of body weight loss between the " before stem cell transplantation evaluation " and each evaluation after stem cell transplantation and after adaptated physical activity sessions.
|
before stem cell transplantation, 1 month , 3 months, 1 year after stem cell transplantation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
patient's ability to attend the classes
Time Frame: 3 months after stem cell transplantation
|
number of adaptated physical activity lessons attended by each patient after stem cell transplantation, calculation of feasibility
|
3 months after stem cell transplantation
|
|
body mass index
Time Frame: before stem cell transplantation, 1 month , 3 months, 1 year after stem cell transplantation
|
Measure of weight and height to evaluate the nutriotional status of a patient
|
before stem cell transplantation, 1 month , 3 months, 1 year after stem cell transplantation
|
|
brachial muscle circumference
Time Frame: before stem cell transplantation , 1 month , 3 months, 1 year after stem cell transplantation
|
evaluation in centimeters of the brachial circumference to evaluate the evolution of the muscle circumference after stem cell transplantation and adaptated physical activity compared to the evaluation before stem cell transplantation.
Using a measuring tape
|
before stem cell transplantation , 1 month , 3 months, 1 year after stem cell transplantation
|
|
grip strength evaluation
Time Frame: before stem cell transplantation , 1 month , 3 months, 1 year after stem cell transplantation
|
it is a measure of muscular strength
|
before stem cell transplantation , 1 month , 3 months, 1 year after stem cell transplantation
|
|
short physical battery test
Time Frame: before stem cell transplantation , 1 month , 3 months, 1 year after stem cell transplantation
|
it is a series of 3 physical tests to evaluate mobility the first test is a balance test (4 points), the second test is an evaluation of a walking speed (4 points) and the third test is a Chair rise test (4 points) The global test is on 12 points (12 is the better score)
|
before stem cell transplantation , 1 month , 3 months, 1 year after stem cell transplantation
|
|
Quality of Life Questionary C30 (QLQ-C30)
Time Frame: before stem cell transplantation , 1 month , 3 months, 1 year after stem cell transplantation
|
it is a score to evaluate the quality of life of patients facing illness The subscales scores are transformed to a 0 to 100 scale, with higher score on functionnal scales indicating better function and higher scores on sumptom scales indicating worse symptoms
|
before stem cell transplantation , 1 month , 3 months, 1 year after stem cell transplantation
|
|
in house developped physical activities questionary
Time Frame: before stem cell transplantation , 1 month , 3 months, 1 year after stem cell transplantation
|
it is a questionnary created especially for this study to evaluate on each step the capacity of each patient to maintain physical activities (social activities, autonomy at home for cooking and hygiene care, autonomy for transport to go to hospital appointments)
|
before stem cell transplantation , 1 month , 3 months, 1 year after stem cell transplantation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: SOLDATI Alizée, CHU NICE, hopital ARCHET 1, hématologie
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 10, 2022
Primary Completion (Estimated)
December 10, 2026
Study Completion (Estimated)
April 10, 2028
Study Registration Dates
First Submitted
May 9, 2022
First Submitted That Met QC Criteria
May 13, 2022
First Posted (Actual)
May 18, 2022
Study Record Updates
Last Update Posted (Actual)
January 30, 2024
Last Update Submitted That Met QC Criteria
January 29, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21-PP-12
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Haematological Malignancy
-
Istituto Scientifico Romagnolo per lo Studio e...Azienda Unità Sanitaria Locale della RomagnaRecruitingHaematological Malignancy | Haematologic DiseaseItaly
-
Melbourne HealthActive, not recruitingHaematological MalignancyAustralia
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceUnknownHaematological MalignancyFrance
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruiting
-
Thomas ZilliUniversity Hospital, GenevaRecruitingHaematological MalignancySwitzerland
-
Helsinki University Central HospitalRecruitingSolid Tumor | Advanced Cancer | Haematological MalignancyFinland
-
Centre Henri BecquerelCompletedHaematological MalignancyFrance
-
Peking University People's HospitalPeking University First Hospital; The First Affiliated Hospital of Zhengzhou... and other collaboratorsCompletedHaematological MalignancyChina
-
Morten LadekarlRecruitingSolid Tumor, Unspecified, Adult | Haematological MalignancyDenmark
-
General Hospital GroeningeCompletedOncology | Haematological MalignancyBelgium
Clinical Trials on 6 sessions of adapted physical activity after stem cell transplant
-
King's College Hospital NHS TrustUnknownMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited Kingdom
-
Centre Hospitalier Henri Duffaut - AvignonRecruiting
-
Washington University School of MedicineNational Cancer Institute (NCI); Incyte Corporation; American Society of HematologyCompletedMyelodysplastic Syndromes | Hodgkin Disease | Non-Hodgkin Lymphoma | Acute Lymphocytic Leukemia | Acute Myelogenous LeukemiaUnited States
-
Nationwide Children's HospitalWithdrawnCrohn's Disease
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedRecurrent Hodgkin Lymphoma | Recurrent Adult Acute Myeloid Leukemia | Recurrent Mantle Cell Lymphoma | Waldenstrom Macroglobulinemia | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Disease | Adult Acute Lymphoblastic Leukemia in Remission | Childhood Acute Lymphoblastic Leukemia in Remission | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Adult B Acute Lymphoblastic... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedNeoplasm Metastasis | Breast NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Therapy-Related Acute Myeloid Leukemia and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Acute Lymphoblastic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts | Recurrent Acute Lymphoblastic... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Recurrent Hodgkin Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Childhood Acute Lymphoblastic Leukemia | Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Prolymphocytic Leukemia | Refractory Chronic... and other conditionsUnited States, Denmark